The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain‐derived neurotrophic factor
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Brain‐derived neurotrophic factor (BDNF) and other neurotrophins induce a unique prolonged activation of mitogen‐activated protein kinase (MAPK) compared with growth factors. Characterization and kinetic and spatial modeling of the signaling pathways underlying this prolonged MAPK activation by BDNF will be important in understanding the physiological role of BDNF in many complex systems in the nervous system. In addition to Shc, fibroblast growth factor receptor substrate 2 (FRS2) is required for the BDNF‐induced activation of MAPK. BDNF induces phosphorylation of FRS2. However, BDNF does not induce phosphorylation of FRS2 in cells expressing a deletion mutant of TrkB (TrkBΔPTB) missing the juxtamembrane NPXY motif. This motif is the binding site for SHC. NPXY is the consensus sequence for phosphotyrosine binding (PTB) domains, and notably, FRS2 and SHC contain PTB domains. This NPXY motif, which contains tyrosine 484 of TrkB, is therefore the binding site for both FRS2 and SHC. Moreover, the proline containing region (VIENP) of the NPXY motif is also required for FRS2 and SHC phosphorylation, which indicates this region is an important component of FRS2 and SHC recognition by TrkB. Previously, we had found that the phosphorylation of FRS2 induces association of FRS2 and growth factor receptor binding protein 2 (Grb2). Now, we have intriguing data that indicates BDNF induces association of the SH2 domain containing protein tyrosine phosphatase, Shp2, with FRS2. Moreover, the PTB association motif of TrkB containing tyrosine 484 is required for the BDNF‐induced association of Shp2 with FRS2 and the phosphorylation of Shp2. These results imply that FRS2 and Shp2 are in a BDNF signaling pathway. Shp2 is required for complete MAPK activation by BDNF, as expression of a dominant negative Shp2 in cells attenuates BDNF‐induced activation of MAPK. Moreover, expression of a dominant negative Shp2 attenuates Ras activation showing that the protein tyrosine phosphatase is required for complete activation of MAPKs by BDNF. In conclusion, Shp2 regulates BDNF signaling through the MAPK pathway by regulating either Ras directly or alternatively, by signaling components upstream of Ras. Characterization of MAPK signaling controlled by BDNF is likely to be required to understand the complex physiological role of BDNF in neuronal systems ranging from the regulation of neuronal growth and survival to the regulation of synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
Patterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233
Klein, R., Nanduri, V., Jing, S., Lamballe, F., Tapley, P., Bryant, S., Cordon-Cardo, C., Jones, K. R., Reichardt, L. F., & Barbacid, M. (1991) · Cell · doi:10.1016/0092-8674(91)90628-c · Cited by 958 · cited 2×
“(2006) 97, 834–845 2006 The Authors Brain-derived neurotrophic factor (BDNF)1 activates the TrkB receptor protein tyrosine kinase (Klein et al. 1991b; Soppet et al. 1991; Squinto et al. 1991).”
BackgroundSoppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820
Self-citationNeurotrophins and Time: Different Roles for TrkB Signaling in Hippocampal Long-Term Potentiation
Kang, H., Welcher, A. A., Shelton, D., & Schuman, E. M. (1997) · Neuron · doi:10.1016/s0896-6273(00)80378-5 · Cited by 481 · cited 1×
“BDNF may also have a role in synaptic function underlying long-term potentiation in the hippocampus (Patterson et al. 1996; Kang et al. 1997).”
BackgroundAraki, T., Nawa, H., & Neel, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306461200 · Cited by 231 · cited 1×
“Moreover, the data support the argument that the mechanism of enhancing MAPK activation may be independent of Grb2 association with Shp2 (Araki et al. 2003).”
Background
Research works printed but not linked: 58
- Alcantara S., 1997, TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy‐induced cell death, J. Neurosci., 17, 3623, 10.1523/JNEUROSCI.17-10-03623.1997 · DOI · Paper page
- 10.1210/mend.12.4.0086 · DOI
- Blaikie P., 1994, A region in Shc distinct from the SH2 domain can bind tyrosine‐ phosphorylated growth factor receptors, J. Biol. Chem., 269, 32031, 10.1016/S0021-9258(18)31593-X · DOI · Paper page
- 10.1016/0003-2697(84)90426-3 · doi:10.1016/0003-2697(84)90426-3
- 10.1101/gad.10.5.566 · DOI
- 10.1016/S1097-2765(00)80287-7 · DOI
- 10.1073/pnas.40.10.1014 · DOI · Paper page
- 10.1074/jbc.270.25.15125 · DOI · Paper page
- 10.1074/jbc.274.16.11321 · DOI
- 10.1523/JNEUROSCI.16-10-03123.1996 · DOI · Paper page
- 10.1016/S0960-9822(95)00081-9 · DOI · Paper page
- 10.1016/S0896-6273(00)81113-7 · DOI · Paper page
- 10.1128/MCB.18.7.3966 · DOI · Paper page
- Harlow E., 1988, Antibodies: a Laboratory Manual
- 10.1038/350158a0 · DOI · Paper page
- 10.1126/science.7527937 · DOI · Paper page
- 10.1096/fasebj.8.10.8050673 · DOI · Paper page
- 10.1016/0092-8674(91)90419-Y · DOI · Paper page
- 10.1016/0896-6273(92)90209-V · DOI · Paper page
- 10.1016/S0092-8674(05)80088-1 · DOI · Paper page
- 10.1016/S0092-8674(00)80252-4 · DOI · Paper page
- 10.1016/0092-8674(91)90442-2 · DOI · Paper page
- 10.1038/341149a0 · DOI · Paper page
- 10.1016/S0022-2143(96)90022-0 · DOI
- 10.1016/0092-8674(95)90401-8 · DOI · Paper page
- 10.1046/j.1471-4159.1998.71051875.x · DOI · Paper page
- 10.1074/jbc.274.14.9861 · DOI · Paper page
- 10.1128/MCB.11.1.143 · DOI · Paper page
- 10.1016/S0021-9258(17)37708-6 · DOI · Paper page
- 10.1023/A:1006342423175 · DOI
- 10.1074/jbc.274.23.16451 · DOI
- 10.1016/S0896-6273(00)80543-7 · DOI · Paper page
- 10.1128/MCB.14.1.759 · DOI · Paper page
- 10.1016/S0306-4522(96)00665-3 · DOI · Paper page
- 10.1002/j.1460-2075.1993.tb05734.x · DOI · Paper page
- 10.1016/S0021-9258(19)49410-6 · DOI · Paper page
- 10.1002/j.1460-2075.1994.tb06421.x · DOI · Paper page
- 10.1128/MCB.20.3.979-989.2000 · DOI · Paper page
- 10.1126/science.278.5346.2075 · DOI · Paper page
- Pear W., 1998, Current Protocols in Molecular Biology
- 10.1016/0896-6273(95)90043-8 · DOI · Paper page
- 10.1182/blood.V90.5.1777 · DOI · Paper page
- Pinon L. G., 1996, Timing of neuronal death in trkA, trkB and trkC mutant embryos reveals developmental changes in sensory neuron dependence on Trk signalling, Development, 122, 3255, 10.1242/dev.122.10.3255 · DOI
- 10.1016/S0896-6273(00)80620-0 · DOI · Paper page
- 10.1128/MCB.17.9.5540 · DOI · Paper page
- 10.1038/sj.emboj.7600522 · DOI
- 10.1523/JNEUROSCI.16-12-03887.1996 · DOI · Paper page
- Scala S., 1996, Brain‐derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity, Cancer Res., 56, 3737
- 10.1146/annurev.ne.19.030196.002335 · DOI · Paper page
- 10.1074/jbc.273.9.4904 · DOI · Paper page
- 10.1038/40864 · DOI · Paper page
- 10.1016/0092-8674(91)90395-F · DOI · Paper page
- 10.1016/0896-6273(94)90223-2 · DOI · Paper page
- 10.1074/jbc.270.31.18205 · DOI · Paper page
- 10.1091/mbc.8.8.1575 · DOI · Paper page
- 10.1074/jbc.273.29.17987 · DOI · Paper page
- 10.1093/oxfordjournals.jbchem.a002955 · DOI
- 10.1074/jbc.272.37.23231 · DOI
Cited by
Takahashi-Kanemitsu, A., Knight, C. T., & Hatakeyama, M. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0339-5 · Cited by 299
Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins
Gotoh, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00840.x · Cited by 268
TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
Gupta, V., You, Y., Gupta, V., Klistorner, A., & Graham, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 258
Bartkowska, K., Paquin, A., Gauthier, A. S., Kaplan, D. R., & Miller, F. D. (2007) · Development · doi:10.1242/dev.008227 · Cited by 226
“…(Ptpn11 – Mouse Genome Informatics), a protein tyrosine phosphatase that is necessary for maximal activation of the MEKERK pathway downstream of TrkB (Easton et al., 2006), is essential for the differentiation, but not survival or proliferation, of cortical precursor cells (Gauthier et al., 2007).”
Backgrounddo Carmo, J. M., da Silva, A. A., Sessums, P. O., Ebaady, S. H., Pace, B. R., Rushing, J. S., Davis, M. T., & Hall, J. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.177 · Cited by 26
Metadata
- Authors
- Easton, J. B., Royer, A. R., & Middlemas, D. S.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-03-29
- Volume
- 97
- Issue
- 3
- Pages
- 834-845
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1531866481
- Cited by
- 66
- References
- 7
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.